Drug costs in the management of metastatic castration-resistant prostate cancer in Canad
The radiopharmaceuticals radium-223 and the pharmacy preparation 177Lu-PSMA-I&T are reimbursed i...
BackgroundTreatment of metastatic prostate cancer is associated with high personal and economic burd...
Introduction. A number of drugs, which improve overall survival and quality of patients’ life, becam...
Objective: Treatment options for metastatic castration resistant prostate cancer (mCRPC) have expand...
Prostate-specific antigen kinetic profiles during androgen deprivation therapy as prognostic factors...
Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finlan
Health economic outcomes of real-world treatment sequencing of androgen receptor-targeted agents (AR...
Background. The average annual increment (5,09 %) of the prostate cancer (PC) incidence was highest ...
BackgroundTreatment of metastatic prostate cancer is associated with high personal and economic burd...
BACKGROUND: The treatment of metastatic castration-resistant prostate cancer has changed with the in...
Background: For Canadian men, prostate cancer (PCa) is the most common cancer and the 3rd leading ca...
Background: Docetaxel is an established first-line therapy to treat metastatic castration-resistant ...
Patients ' and urologists ' preferences for prostate cancer treatment: A discrete choic...
Terazosin treatment suppresses basic fibroblast growth factor expression in the rat ventral prostate...
INTRODUCTION: Health economic outcomes of real-world treatment sequencing of androgen receptor-targe...
The radiopharmaceuticals radium-223 and the pharmacy preparation 177Lu-PSMA-I&T are reimbursed i...
BackgroundTreatment of metastatic prostate cancer is associated with high personal and economic burd...
Introduction. A number of drugs, which improve overall survival and quality of patients’ life, becam...
Objective: Treatment options for metastatic castration resistant prostate cancer (mCRPC) have expand...
Prostate-specific antigen kinetic profiles during androgen deprivation therapy as prognostic factors...
Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finlan
Health economic outcomes of real-world treatment sequencing of androgen receptor-targeted agents (AR...
Background. The average annual increment (5,09 %) of the prostate cancer (PC) incidence was highest ...
BackgroundTreatment of metastatic prostate cancer is associated with high personal and economic burd...
BACKGROUND: The treatment of metastatic castration-resistant prostate cancer has changed with the in...
Background: For Canadian men, prostate cancer (PCa) is the most common cancer and the 3rd leading ca...
Background: Docetaxel is an established first-line therapy to treat metastatic castration-resistant ...
Patients ' and urologists ' preferences for prostate cancer treatment: A discrete choic...
Terazosin treatment suppresses basic fibroblast growth factor expression in the rat ventral prostate...
INTRODUCTION: Health economic outcomes of real-world treatment sequencing of androgen receptor-targe...
The radiopharmaceuticals radium-223 and the pharmacy preparation 177Lu-PSMA-I&T are reimbursed i...
BackgroundTreatment of metastatic prostate cancer is associated with high personal and economic burd...
Introduction. A number of drugs, which improve overall survival and quality of patients’ life, becam...